RecruitingNCT03004326
Clinical Transcriptomics in Systemic Vasculitis (CUTIS)
Sponsor
Peter Merkel
Enrollment
50 participants
Start Date
Jan 1, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
Multi-center observational study to evaluate the histopathology and transcriptome of cutaneous lesions in patients with several different types of vasculitis.
Eligibility
Min Age: 5 Years
Plain Language Summary
Simplified for easier understanding
This study collects skin biopsy samples from patients who have signs of vasculitis — inflammation of blood vessels — in their skin. Researchers use advanced genetic analysis (transcriptomics) to study which genes are active in the affected tissue, with the goal of better understanding different types of vasculitis and improving diagnosis.
You may be eligible if:
- You have a skin lesion (such as purple spots, raised purplish marks, nodules, ulcers, or hive-like lesions) believed to be caused by active vasculitis
- You have a suspected or confirmed diagnosis of a form of vasculitis (e.g., IgA vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, polyarteritis nodosa, cryoglobulinemic vasculitis, or others)
- You are 5 years of age or older
- You are willing and able to provide informed consent (or assent for minors)
You may NOT be eligible if:
- You are younger than 5 years old
- You are not a good candidate for a skin biopsy, or the risks of biopsy outweigh the benefits
- You have very low blood counts (low white cells, platelets, or hemoglobin)
- You have an active infection at or near the biopsy site, poor circulation, or other conditions that increase biopsy risk
- You are pregnant or nursing
- You are unable to provide informed consent
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03004326
Related Trials
A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases
NCT0651288315 locations
Study to Evaluate Avacopan in Combination With a Rituximab or Cyclophosphamide-containing Regimen, in Children From 6 Years to < 18 Years of Age With AAV.
NCT0632160132 locations
SysteMic vAsculitis pRognosis and ouTcome
NCT075861371 location
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
NCT0500398647 locations
The RheumSafer Study: Improving Medication Appropriateness in People With Rheumatic Conditions
NCT072786091 location